| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Business Officer
1 company
Beaurang Pierre is a Chief Business Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $221K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $29.86 | $223,925.93 | -41.6% | +10.2% | -34.7% | |
| Jul 12, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $23.92 | $179,418.70 | -45.3% | +17.2% | -33.2% | |
| Jun 10, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $29.37 | $220,248.49 | -33.5% | +20.6% | -65.4% | |
| May 10, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $26.49 | $198,644.22 | -30.7% | +15.2% | -64.8% | |
| Apr 12, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $27.28 | $204,631.89 | -30.7% | -10.2% | -50.0% | |
| Mar 8, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 7,500 | $37.02 | $277,678.49 | -60.5% | - | - | |
| Feb 18, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Business Officer | Sale+OE | 15,000 | $35.49 | $532,351.76 | -40.6% | - | - |